United States · 
What does CDIB BioScience Ventures invest in?
CDIB BioScience Ventures invests most often at Series B and Series A (67% of the rounds on record), in sectors such as Health Care and Hospital.
CDIB BioScience Ventures highlights
- 01
12 rounds on record
- 02
Mostly Series B and Series A: 67% of its rounds
- 03
Sole investor in 1 rounds, median $4.9M
- 04
2 exits from the portfolio
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- Health CareHospital
- Based in
- United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first12 appearances
- 2015
1 round
- Jun
- 2007
2 rounds
- Mar
- Jan
- 2006
3 rounds
- Dec
- Dec
- Nov
- 2005
1 round
- Nov
- 2004
1 round
- Jun
- 2003
2 rounds
- Dec
- Apr
- 2002
1 round
- Dec
- 2001
1 round
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed2 in all
Somaxon PharmaceuticalsBought by Pernix TherapeuticsUndisclosedMar 2013
Xanthus PharmaceuticalsBought by AntisomaUndisclosedMay 2008
An exit counts when it came after the firm's first round in the company. From historical deal records.